The Implementation Process for Pharmacogenomic Testing for Cancer-Targeted Therapies.

Recent advances in genomic medicine have led to the availability of genomic tests that have the potential to improve population health, yet the process for obtaining these tests and getting them reimbursed by insurers has not been described. The objective of this study was to describe the process of ordering pharmacogenomic tests by interviewing providers, patients, and laboratories about cancer-related pharmacogenomic tests. We interviewed patients who were prescribed, providers who prescribed medications that should be guided by pharmacogenomic testing, and individuals from diagnostic laboratories.

Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.

Insurance coverage policies are a major determinant of patient access to genomic tests. The objective of this study was to examine differences in coverage policies for guideline-recommended pharmacogenomic tests that inform cancer treatment. We analyzed coverage policies from eight Medicare contractors and 10 private payers for 23 biomarkers (e.

Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.

Genomic tests are the fastest growing sector in medicine and medical science, yet there remains a dearth of research on access to pharmacogenomic tests and medications. The objective of this study is to explore providers' and patients' experiences and views on test access as well as strategies used for gaining access. We interviewed clinicians who prescribed medications that should be guided by pharmacogenomic testing and patients who received those prescriptions.

An analysis of blood lead data in clinical records by external data on lead pipes and age of household.

This study examined the possibility that lead pipes in the drinking water distribution system were elevating the blood lead levels of children in London, Ontario, Canada. Based on their postal codes, 164 children admitted between 1984 and 1989 to an institution for the behaviorally disordered or developmentally challenged were categorized according to whether they lived in the area of the city known by the local Public Utilities Commission to be serviced by lead pipes. Analysis of covariance was used to obtain confounder-adjusted geometric means in each area.